KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803.
Ogino S, Meyerhardt JA, Irahara N, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Schaefer P, Whittom R, Hantel A, Benson AB 3rd, Goldberg RM, Bertagnolli MM, Fuchs CS; Cancer and Leukemia Group B; North Central Cancer Treatment Group; Canadian Cancer Society Research Institute; Southwest Oncology Group.
Ogino S, et al. Among authors: bertagnolli mm.
Clin Cancer Res. 2009 Dec 1;15(23):7322-9. doi: 10.1158/1078-0432.CCR-09-1570. Epub 2009 Nov 24.
Clin Cancer Res. 2009.
PMID: 19934290
Free PMC article.
Clinical Trial.